EVAg

RNA extracted from infectious cell culture supernatant containing SARS-CoV-2 (strain hCoV-19/Slovenia/LP3/3/23 (lineage B.1.1.529.5.2.1.7, BF.7).

RNA extracted from infectious cell culture supernatant containing SARS-CoV-2 (strain hCoV-19/Slovenia/LP3/2/23 (lineage BQ.1).

RNA extracted from infectious cell culture supernatant containing SARS-CoV-2 (strain hCoV-19/Slovenia/LP3/1/23 (lineage Omicron, XBB).

RNA extracted from infectious cell culture supernatant containing SARS-CoV-2 (strain hCoV-19/Slovenia/232863/22 (lineage Omicron, BQ.1.1).

RNA SARS-CoV-2 strain B.1.617 (India). Product only available via TNA.

RNA extracted from infectious cell culture supernatant containing SARS-CoV-2 (strain hCoV-19/Slovenia/57573/21 (lineage B.1.525).

In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the E gene . Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the RdRP gene . Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

genomic RNA from culture supernatant of UVE/SARS-CoV-2/2021/FR/1299-ex SA. 100µL containing E+04 copies/µl provided in AVE buffer + RNA carrier.

genomic RNA from culture supernatant of SARS-CoV-2/2021/FR/7b (lineage B 1. 1 .7, ex UK). 100µL containing 1.25E+04 copies/µl provided in AVE buffer + RNA carrier.

RNA extracted from infectious cell culture supernatant containing SARS-CoV-2 (strain hCoV-19/Slovenia/71693/21 (lineage B.1.351).

Panel consists of (cell-culture) RNA from different coronaviruses (HCoV-Nl63, HCoV-229E, HCoV-OC43, MERS-CoV and SARS-CoV) and is intended for use as control of specificity of molecular assays. This panel contains sufficient RNA for t least 5 experiments. "Disclaimer: Import permit may be needed in your country for SARS-CoV full virus RNA. If yes, please indicate so in your online enquiry". Product for Alphacoronavirus and Betacoronavirus. ------------------ NB: indicated price is only valid for non-profit laboratories. Commercial users will be contacted about pricing.

In vitro transcribed RNA for a specific SARS-coronavirus real time PCR.

In vitro transcribed RNA for new Betacoronavirus virus (hCoV-EMC) real time PCR targeting region upstream of the E gene (upE). Reference: Corman et. Al., Eurosurveillance, Volume 17, Issue 39, 27 September 2012

In vitro transcribed RNA for new Betacoronavirus virus (hCoV-EMC) real time PCR targeting region within the open reading frame 1a. Reference: Corman/Mueller et al., Eurosurveillance, Volume 17, Issue 49, 06 December 2012

The in vitro transcribed RNA is the control for the first-line screening assay termed E gene assay. The SARS-CoV full virus RNA is required to control the two confirmatory assays. Dislaimer: Import permit maybe be needed in your country for the SARS-CoV full virus RNA. If yes, please indicate so in your online enquiry.